Cargando…
The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis
High-flow nasal therapy significantly reduces exacerbation rates and improves quality of life in patients with stable bronchiectasis. High-flow nasal therapy is therefore a potential treatment option for patients with bronchiectasis. https://bit.ly/2JFXuQc
Autores principales: | Good, William R., Garrett, Jeffrey, Hockey, Hans U.P., Jayaram, Lata, Wong, Conroy, Rea, Harold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869600/ https://www.ncbi.nlm.nih.gov/pubmed/33585655 http://dx.doi.org/10.1183/23120541.00711-2020 |
Ejemplares similares
-
Sputum procalcitonin levels in patients admitted to hospital with acute exacerbations of bronchiectasis
por: Good, William, et al.
Publicado: (2020) -
Neurological and Sleep Disturbances in Bronchiectasis
por: Phua, Chun Seng, et al.
Publicado: (2017) -
Sputum procalcitonin: a potential biomarker in stable bronchiectasis
por: Good, William, et al.
Publicado: (2021) -
Bronchiectasis in the Last Five Years: New Developments
por: Khoo, Jun Keng, et al.
Publicado: (2016) -
Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy
por: Milne, Richard J, et al.
Publicado: (2022)